AAP
TXG icon

Arax Advisory Partners’s 10x Genomics TXG Stock Holding History

Arax Advisory Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
90,139
+78,468
+672% +$2.06M 0.02% 611
2026
Q1 		$248K Buy
11,671
+5,053
+76% +$101K 0.01% 978
2025
Q4 		$108K Sell
6,618
-84,465
-93% -$1.28M ﹤0.01% 1304
2025
Q3 		$1.06M Buy
91,083
+88,556
+3,504% +$1.15M 0.02% 624
2025
Q2 		$29.3K Buy
2,527
+1,728
+216% +$15.8K ﹤0.01% 1487
2025
Q1 		$6.98K Sell
799
-4,054
-84% -$51.1K ﹤0.01% 1671
2024
Q4 		$69.7K Buy
4,853
+4,324
+817% +$68.2K ﹤0.01% 794
2024
Q3 		$11.9K Buy
+529
New +$10.9K ﹤0.01% 1329

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arax Advisory Partners's TXG Position: Q2 2026 in Review

Arax Advisory Partners increased its 10x Genomics (TXG) stake by 672% in Q2 2026, buying an estimated $2.06M and bringing the position to 90,139 shares worth $3.46M. The position accounts for 0.02% of the portfolio, ranked #611.

Arax Advisory Partners first reported a position in TXG in Q3 2024 and has held it in 8 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Arax Advisory Partners held 90,139 shares of 10x Genomics worth $3.46M as of Q2 2026.
  • Arax Advisory Partners bought 78,468 10x Genomics shares in Q2 2026, an estimated $2.06M.
  • 10x Genomics made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #611 holding.
  • Arax Advisory Partners first reported a position in 10x Genomics in Q3 2024 and has held it in 8 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.